Ischemix, LLC is a biotechnology company based in Grafton, Massachusetts, specializing in the development of innovative therapies for ischemic conditions. The company focuses on advancing treatments that target tissue preservation and recovery in various medical scenarios, particularly in cardiovascular and neurological applications. By leveraging cutting-edge research and technology, Ischemix aims to improve patient outcomes and enhance the efficacy of existing treatment protocols in the healthcare landscape.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

11 Patents

#1 in Grafton, MA

#1,661 in Massachusetts

#27,514 in US

#51,761 in the World

Grafton, MA, United States of America

Ischemix, LLC

Forward Citations = 38

7 inventors:

Steven A Kates (8 out of 24 patents)

Reinier Beeuwkes (8 out of 13 patents)

Ralph Casale (8 out of 11 patents)

4. Alan S Lader (8 out of 8 patents)

5. Alexander Baguisi (8 out of 11 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Ischemix, LLC. Retrieved from https://idiyas.com/company/ischemix

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

5 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]